Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study

BACKGROUND: Fibroblast growth factor 23 (FGF23) plays an important role in chronic kidney disease (CKD)‐related mineral and bone disorders. High FGF23 levels are associated with increased risk of anaemia in non‐haemodialysis CKD patients. FGF23 also negatively regulates erythropoiesis in mice. We hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Tomoko, Zhao, Junhui, Fuller, Douglas S., Hanafusa, Norio, Hasegawa, Takeshi, Fujino, Hiroshi, Nomura, Takanobu, Zee, Jarcy, Young, Eric, Robinson, Bruce M., Nangaku, Masaomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754421/
https://www.ncbi.nlm.nih.gov/pubmed/32743932
http://dx.doi.org/10.1111/nep.13765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754421/
https://www.ncbi.nlm.nih.gov/pubmed/32743932
http://dx.doi.org/10.1111/nep.13765

Ejemplares similares